Hinge Health (NYSE:HNGE) Coverage Initiated at William Blair

Investment analysts at William Blair initiated coverage on shares of Hinge Health (NYSE:HNGE) in a research note issued to investors on Monday, Marketbeat Ratings reports. The firm set an “outperform” rating on the stock.

HNGE has been the topic of a number of other research reports. KeyCorp began coverage on Hinge Health in a research report on Monday. They issued an “overweight” rating and a $45.00 target price on the stock. Barclays assumed coverage on Hinge Health in a research report on Monday. They set an “overweight” rating and a $43.00 price target on the stock. Wall Street Zen raised Hinge Health to a “hold” rating in a report on Monday, June 2nd. Piper Sandler began coverage on shares of Hinge Health in a report on Monday. They set an “overweight” rating and a $41.00 target price on the stock. Finally, Royal Bank Of Canada started coverage on shares of Hinge Health in a research report on Monday. They set an “outperform” rating and a $45.00 price target on the stock. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $46.00.

Hinge Health Stock Up 3.8%

Shares of HNGE stock opened at $37.57 on Monday. Hinge Health has a 12 month low of $33.42 and a 12 month high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.